Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

The incidence of cytomegalovirus infection in lung transplant recipients under universal prophylaxis with intravenous ganciclovir.

The incidence of cytomegalovirus infection in lung transplant recipients under universal prophylaxis with intravenous ganciclovir. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • The incidence of cytomegalovirus infection in lung transplant recipients under universal prophylaxis with intravenous ganciclovir. Abstract Text:

    regina Regina ,tatiana michelonTatiana Michelon, wurdig Wurdig,iara fagundesIara Fagundes,sadi schioSadi Schio,leticia sanchezLeticia Sanchez, camargo Camargo,teresa c sukkienikTeresa C Sukkienik,alessandro c pasqualottoAlessandro C Pasqualotto,jorge neumannJorge Neumann,regina schröederRegina Schröeder,tatiana michelonTatiana Michelon,joão wurdigJoão Wurdig,iara fagundesIara Fagundes,sadi schioSadi Schio,leticia sanchezLeticia Sanchez,josé j camargoJosé J Camargo,teresa c sukkienikTeresa C Sukkienik,alessandro c pasqualottoAlessandro C Pasqualotto,jorge neumannJorge Neumann,

    The best strategy for control of cytomegalovirus (CMV) infection in lung transplant patients is still not determined. The aim of this study was to document the incidence of CMV infection in a cohort of lung transplant recipients under universal prophylaxis with intravenous ganciclovir. All patients received immunosuppressive regimens consisting of cyclosporine, azathioprine, and prednisone. Regardless of CMV serostatus, intravenous ganciclovir was prescribed for every patient in the first 3 months post-transplantation. CMV infection was defined as the detection of CMV pp65 in leukocytes. Eighty-two lung transplant patients were included over a 5-year period. The incidence of CMV infection in the first year post-transplantation was 68.3%, occurring after a median length of 114 days (range, 26-343 days). This study revealed a high incidence of CMV infection in the first year following lung transplantation despite prolonged universal ganciclovir prophylaxis.

    The incidence of cytomegalovirus infection in lung transplant recipients under universal prophylaxis with intravenous ganciclovir. Publishing Authors By Initials

    r R ,t michelonT Michelon,j wurdigJ Wurdig,i fagundesI Fagundes,s schioS Schio,l sanchezL Sanchez,jj camargoJJ Camargo,tc sukkienikTC Sukkienik,ac pasqualottoAC Pasqualotto,j neumannJ Neumann,r schröederR Schröeder,t michelonT Michelon,j wurdigJ Wurdig,i fagundesI Fagundes,s schioS Schio,l sanchezL Sanchez,jj camargoJJ Camargo,tc sukkienikTC Sukkienik,ac pasqualottoAC Pasqualotto,j neumannJ Neumann,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    The incidence of cytomegalovirus infection in lung transplant recipients under universal prophylaxis with intravenous ganciclovir. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: The Brazilian journal of infectious diseases : an

    VOLUME: 11

    Page Numbers: 212-4

    Journal Abbreviation: Braz J Infect Dis

    ISSN: 1413-8670

    DAY: 12

    MONTH: Apr

    YEAR: 2007

    The incidence of cytomegalovirus infection in lung transplant recipients under universal prophylaxis with intravenous ganciclovir. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9812937

    The incidence of cytomegalovirus infection in lung transplant recipients under universal prophylaxis with intravenous ganciclovir. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: The incidence of cytomegalovirus infection in lung transplant recipients under universal prophylaxis with intravenous ganciclovir. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for The incidence of cytomegalovirus infection in lung transplant recipients under universal prophylaxis with intravenous ganciclovir.

    AFFILIATION: Laboratory of Transplant Immunology, Santa Casa Complexo Hospitalar, Avenida Independência 75, 94035-075 Porto Alegre, RS, Brazil. regina@santacasa.tch.br

    Country: Brazil

    Brazil Research PublicationBrazil Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Braz J Infect Dis

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    The incidence of cytomegalovirus infection in lung transplant recipients under universal prophylaxis with intravenous ganciclovir Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News